TCL Archive ODAC Says Clear Clinical Benefit Required When Sponsors Claim Progression Delay July 17, 2009
TCL Archive ONS, ASCO, AACR Growth Surge Continues; Flex Political Muscles During DC Meetings June 8, 1990
TCL Archive FDA Vs. NCI: Nothing Has Changed; Chabner “Frustrated” By Flutamide Delay October 21, 1988
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive In Brief: Data Availability From Cancer Survey Presents Problems – Who Gets It first, Confidentiality August 30, 1974
